maheshwariandco

  Protection of IPR provides fair incentives to innovations, helps prevent potential IP infringement and enables inventors from defending infringement cases. Specifically in the pharma sector, the process of identifying ones IP, protecting ones IP and commercialising the asset provides exclusive rights to inventors of life-saving drugs to market their products openly, reap profits from their R&D efforts and also prevent others from unauthorized manufacturing or sale of these products. IP protection in the pharmaceutical sector holds significant importance, as it provides commercial advantages and also holds public health considerations. Some key ways in which the Indian pharmaceutical industry can effectively manage its IPRs are outlined below. 1. Patent registration It is imperative for pharmaceutical companies to obtain a registration for its novel drug or medical equipment or process. For obtaining a patent, the drug/ equipment/ medical process must be novelty, inventive and...

  The Insolvency and Bankruptcy Code, 2016 (IBC) provides the legal foundation for insolvency and bankruptcy proceedings in India. It consolidates and modernizes laws dealing with financial distress across corporate entities, individuals, and partnership firms. For individuals and partnership firms, Part III of the IBC lays down a dedicated, time-bound mechanism to address insolvency, encourage orderly debt resolution, and ensure fairness between debtors and creditors. Scope and Applicability of Part III of the IBC Part III governs insolvency resolution and bankruptcy proceedings for individuals and partnership firms. It primarily applies to two distinct groups: 1. Personal Guarantors to Corporate Debtors These are individuals who have given personal guarantees for loans taken by corporate entities. Their insolvency proceedings are closely linked to the insolvency of the corporate debtor. 2. Other Individuals and Partnership Firms This category covers individuals and firms facing ...